Stereotactic Radiosurgery Keeps Brain Metastases at Bay.
According to two clinical trials presented at the American Society for Radiation Oncology's 2016 annual meeting, stereotactic radiosurgery following surgical removal of brain metastases decreases the risk of local recurrence and, compared with whole-brain radiotherapy, offers patients a better quality of life. As such, postoperative stereotactic radiosurgery should be considered a new standard of care for patients whose cancer has spread to the brain.
D001932:Brain Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000556:secondary / Q000601:surgery*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D011788:Quality of Life; D016634:Radiosurgery; D016019:Survival Analysis